ACTON, Mass.– Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at two upcoming virtual investor conferences:
- The Canaccord 41st Annual Growth Conference on Wednesday, August 11, 2021 at 11:00 a.m. (Eastern Time)
- The UBS Genomics 2.0 and MedTech Innovations Summit on Thursday, August 12, 2021 at 4:00 p.m. (Eastern Time)
To listen to the live audio webcast of the presentation, please visit investors.insulet.com. A replay of the audio webcast will also be available following the event.
